Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) shares, rose in value, with the stock price down by -1.05% to the previous day’s close as strong demand from buyers drove the stock to $8.52.
Actively observing the price movement in the last trading, the stock closed the session at $8.61. Referring to stock’s 52-week performance, its high was $16.62, and the low was $4.52. On the whole, MRVI has fluctuated by 19.83% over the past month.
As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.03, which is expected to increase to $0.01 for fiscal year -$0.02 and then to about $0.05 by fiscal year 2025. Data indicates that the EPS growth is expected to be -166.70% in 2025, while the next year’s EPS growth is forecast to be 350.00%.
Analysts have estimated the company’s revenue for the quarter at $60.55 million, with a low estimate of $58.7 million and a high estimate of $62.2 million. According to the average forecast, sales growth in current quarter could jump down -23.40%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $272.13 million, representing a decrease of -5.80% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that MRVI’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of Hold while long term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of MRVI currently trading nearly 5.56% and 22.59% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.04, while the 7-day volatility ratio is showing 4.44% which for the 30-day chart, stands at 6.32%. Furthermore, Maravai LifeSciences Holdings Inc (MRVI)’s beta value is 0.00, and its average true range (ATR) is 0.49.
A comparison of Maravai LifeSciences Holdings Inc (MRVI) with its peers suggests the former has fared considerably weaker in the market. MRVI showed an intraday change of -1.05% in last session, and over the past year, it shrunk by -37.17%%.
Data on historical trading for Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) indicates that the trading volumes over the past 10 days have averaged 2.97 million and over the past 3 months, they’ve averaged 2.77 million. According to company’s latest data on outstanding shares, there are 132.23 million shares outstanding.
Nearly 19.29% of Maravai LifeSciences Holdings Inc’s shares belong to company insiders and institutional investors own 86.17% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.35 million shares as on Mar 15, 2024, resulting in a short ratio of 1.9. According to the data, the short interest in Maravai LifeSciences Holdings Inc (MRVI) stood at 5.56% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 6.21 million. The stock has risen by 30.08% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRVI stock heading into the next quarter.
